Related references
Note: Only part of the references are listed.Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
Hong-Yan Cai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease
Yue Cao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease
Peng Feng et al.
NEUROPHARMACOLOGY (2018)
Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
Christian Holscher
NEUROPHARMACOLOGY (2018)
Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages
Odile Poirel et al.
SCIENTIFIC REPORTS (2018)
D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
Yanwei Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Novel GLP-1R/GIPR co-agonist twincretin is neuroprotective in cell and rodent models of mild traumatic brain injury
Ian A. Tamargo et al.
EXPERIMENTAL NEUROLOGY (2017)
A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease
Jaishree Jalewa et al.
NEUROPHARMACOLOGY (2017)
A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model
Lijuan Shi et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Lixisenatide attenuates the detrimental effects of amyloid β protein on spatial working memory and hippocampal neurons in rats
Hong-Yan Cai et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
O-GlcNAcylation of protein kinase A catalytic subunits enhances its activity: a mechanism linked to learning and memory deficits in Alzheimer's disease
Shutao Xie et al.
AGING CELL (2016)
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
Henrik H. Hansen et al.
BRAIN RESEARCH (2016)
A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF
Chenhui Ji et al.
BRAIN RESEARCH (2016)
Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model
Yanwei Li et al.
NEUROPHARMACOLOGY (2016)
A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain
Lijun Cao et al.
NEUROREPORT (2016)
A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat
Ling Han et al.
NEUROREPORT (2016)
Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases
Christian Hoelscher
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK3β Pathway in Streptozotocin-Induced Alzheimer Rat Model
Chong Gao et al.
BRAIN PATHOLOGY (2014)
Transcriptional Analysis of Apoptotic Cerebellar Granule Neurons Following Rescue by Gastric Inhibitory Polypeptide
Barbara Maino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
Christian Hoelscher
JOURNAL OF ENDOCRINOLOGY (2014)
Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress
Mohit K. Sharma et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
D-Ala2GIP Facilitated Synaptic Plasticity and Reduces Plaque Load in Aged Wild Type Mice and in an Alzheimer's Disease Mouse Model
Emilie Faivre et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
THE INCRETIN ANALOGUE D-ALA2GIP REDUCES PLAQUE LOAD, ASTROGLIOSIS AND OXIDATIVE STRESS IN AN APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE
A. M. Duffy et al.
NEUROSCIENCE (2013)
New animal models of Alzheimer's disease that display insulin desensitization in the brain
Chong Gao et al.
REVIEWS IN THE NEUROSCIENCES (2013)
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Brian Finan et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
(Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains
Lin Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Neuroprotective Effect of Cyclooxygenase Inhibitors in ICV-STZ Induced Sporadic Alzheimer's Disease in Rats
Dinesh Kumar Dhull et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
Asger Lund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Tau Mediated Neurodegeneration: An Insight into Alzheimer's Disease Pathology
M. Obulesu et al.
NEUROCHEMICAL RESEARCH (2011)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
GLP-1 Receptor Stimulation Reduces Amyloid-beta Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
Yazhou Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
EEG, Activity, and Sleep Architecture in a Transgenic A beta PPswe/PSEN1(A246E) Alzheimer's Disease Mouse
Amar Jyoti et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Insulin-resistant brain state (IRBS) changes membrane composition of fatty acids in temporal and entorhinal brain cortices of rats: relevance to sporadic Alzheimer's disease?
Konstanze Plaschke et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
Tauheed Ishrat et al.
BRAIN RESEARCH (2009)
Destabilization of the Postsynaptic Density by PSD-95 Serine 73 Phosphorylation Inhibits Spine Growth and Synaptic Plasticity
Pascal Steiner et al.
NEURON (2008)
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Lin Li et al.
BRAIN RESEARCH REVIEWS (2007)
Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain
Zhihou Liang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Alzheimer's Disease: Clinical features, pathogenesis, and treatment
Kaye L. Rathmann et al.
ANNALS OF PHARMACOTHERAPY (2007)
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Jian-Zhi Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Increased pancreatic β-cell proliferation mediated by CREB binding protein gene activation
Mehboob A. Hussain et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Synapse formation and function is modulated by the amyloid precursor protein
Christina Priller et al.
JOURNAL OF NEUROSCIENCE (2006)
CREB activity maintains the survival of cingulate cortical pyramidal neurons in the adult mouse brain
Hushan Ao et al.
MOLECULAR PAIN (2006)
Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity
D Puzzo et al.
JOURNAL OF NEUROSCIENCE (2005)
Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression
SJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Signal transduction during amyloid-β-peptide neurotoxicity:: role in Alzheimer disease
RA Fuentealba et al.
BRAIN RESEARCH REVIEWS (2004)
Hyperinsulinemia and risk of Alzheimer disease
JA Luchsinger et al.
NEUROLOGY (2004)
Entry of exendin-4 into brain is rapid but may be limited at high doses
AJ Kastin et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
AJ Kastin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cell death mechanisms in neurodegeneration
KA Jellinger
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)
Size of CA1-evoked synaptic potentials is related to theta rhythm phase in rat hippocampus
BP Wyble et al.
JOURNAL OF NEUROPHYSIOLOGY (2000)
Share Paper
